Search Results - Jie Weng
-
1
Effect of general anesthesia on postoperative pulmonary embolism
Published 2025-12-01Get full textBackground The influence of anesthesia type and duration on the occurrence of pulmonary embolism (PE) after surgery remains controversial. This study investigates the association between anesthesia type and duration with postoperative PE.Methods A retrospective cohort of adult patients undergoing su...
Article -
2
The multifaceted biomimetic titanium implant promotes bone integration with sequential antibacterial and immune modulation properties
Published 2025-09-01Get full textTitanium (Ti) and its alloy implants often face issues such as insufficient tissue adhesion and vulnerability of the bio inert surface. Given that the long-term stability of implants depends on their perfect integration with the surrounding tissues to withstand various environmental stresses, curren...
Article -
3
Dihydroartemisinin targets the miR-497-5p/SOX5 axis to suppress tumor progression in non-small cell lung cancer
Published 2025-07-01Get full textIntroductionNon-small cell lung cancer (NSCLC) remains a lethal malignancy with limited therapeutic options. Although dihydroartemisinin (DHA) exhibits anticancer properties, its mechanisms in NSCLC are incompletely understood. This study investigated the role of the miR-497-5p/SOX5 axis in mediatin...
Article -
4
Losing brain networks during death
Published 2025-07-01Get full textAbstract Death represents the end of all living organisms. The pattern of brain activity disappearance following death, however, has not been fully elucidated. Here we investigated brain activity dynamics following cardiac arrest using ultra‐high field 11.7 T magnetic resonance imaging (MRI) in long...
Article -
5
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lun...
Published 2025-07-01Get full textBackground: SIBP04 is a biosimilar of bevacizumab (Avastin®, Roche, Basel, Switzerland). This study evaluated the equivalence of SIBP04 to Avastin® as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer (nsqNSCLC). Methods: In this randomized, double-blind...
Article